MyLooks® Injectable Filler Voluma™ Now FDA-Approved to Add Volume

FDA-Approved injectable filler uses VYCROSS™ technology for smoother facial contour.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Voluma™ injectables use VYCROSS™ technology, which is a cohesive gel that is easily injected into the skin to minimize discomfort while providing natural and smooth contours to the facial features.

Florida (PRWEB) March 11, 2014

MyLooks® Inc., now offers the latest VYCROSS™ technology with facial injectable filler Juvèderm Voluma™ XC.

Juvèderm Voluma™ XC was FDA-approved in October 2013, to correct age-related volume loss in areas of the mid-face and cheeks. Juvèderm Voluma™ XC is the first and only injectable filler used for volume loss in adults 21 and over, that uses VYCROSS™ technology.

In the past, aesthetic injectable fillers were typically used to fill fine-lines and wrinkles in the facial area, however, innovations in cosmetic surgery have allowed for fillers to add or replace volume to the mid-face and around the cheeks. Loss of volume around the cheekbones is one of the first signs of aging, and with Voluma™ XC, now injectable fillers patients are able to replace lost volume or add volume for better facial contour.

“Juvèderm Voluma™ XC has highly effective and durable results,” said Dr. Lawrence M. Korpeck, board-certified plastic surgeon from MyLooks® Boca Raton. “Voluma™ injectables use VYCROSS™ technology, which is a cohesive gel that is easily injected into the skin to minimize discomfort while providing natural and smooth contours to the facial features.”

VYCROSS™ technology is the primary difference in Juvèderm Voluma™ XC and the latest innovation in facial filler injectables from Juvèderm®. Voluma™ XC is formulated with a 90% low-molecular-weight hyaluronic acid and a 10% high-molecular-weight hyaluronic acid, where most fillers use a 100% high-molecular-weight hyaluronic acid. VYCROSS™ technology has a higher viscosity that enables it to retain its molecular structure after treatment, and the results are long-lasting due to the higher resistance to degradation caused by free radicals and enzymes.

Juvèderm Voluma™ XC is produced by Allergen Inc., a leader in medical aesthetics. Allegan Inc. earned a top position in the marketplace with the release of Botox® Cosmetic, Latisse® and Juvèderm® Ultra and Ultra Plus™ dermal fillers.

About MyLooks®
Florida-based MyLooks® is a leading cosmetic and surgical service provider dedicated to helping women and men achieve their personal aesthetic goals. Each MyLooks® clinic provides a high-quality total experience, including plastic surgeons certified by the American Board of Plastic Surgery, procedure customization, a safe and clean environment, patient financing and complimentary consultations. More information is available at http://www.MyLooks.com.


Contact

Follow us on: Contact's Google Plus

Attachments

FDA-Approved Injectables FDA-Approved Injectables

For added volume to areas of the mid-face.